Higher incidence of HBeAg seroclearance with tenofovir alafenamide fumarate than entecavir in HBeAg-positive patients with chronic hepatitis B
Fields of Study & Subjects
Hepatitis B Virus Studies
Drug-Induced Hepatotoxicity and Protection
Hepatitis C virus research
Publication details
- Journal / source
- Clinics and Research in Hepatology and Gastroenterology
- Publisher
- Elsevier BV
- Volume
- 50
- Issue
- 3
- Pages
- 102783–102783
- Publication date
- 10 February 2026
- Language
- EN